ESMO Asia 2017 Congress: News

All the oncology news and press releases that came out of ESMO Asia 2017 Congress

Filter

Date Title Topic
21 Nov 2017 No Impact of Low Molecular Weight Heparin in Localised Lung Cancer Lung and other thoracic tumours
19 Nov 2017 Cost Benefit Analysis in Hong Kong Decides Against Adding Abiraterone Plus Prednisone to ADT in Metastatic Hormone Sensitive Prostate Cancer Genitourinary cancers - Bioethics, legal and economic issues - Anticancer agents & Biologic therapy
19 Nov 2017 Genomic Data May Provide Therapeutic Options in Advanced HCC Gastrointestinal cancers - Translational research
19 Nov 2017 Appetite Stimulants May Provide the Most Rapid Improvement in Cachexia Palliative and supportive care
18 Nov 2017 ESMO Asia 2017 Press Release: Osimertinib Improves Progression-free Survival in Asian EGFR-mutated Lung Cancer Patients
18 Nov 2017 ESMO Asia 2017 Press Release: Study Shows New Second Line Therapy for Metastatic Colorectal Cancer is Effective and Safe
18 Nov 2017 ESMO Asia 2017 Press Release: Global Analysis Looks at Policy Gaps and How to Advance Breast Cancer Control in Asia
18 Nov 2017 Fewer Surgery-Related Complications Reported With Robotic Assisted Surgery Head and neck cancers - Gastrointestinal cancers - Gynaecologic malignancies
18 Nov 2017 Trifluridine/Tipiracil Improves Survival in Patients with Metastatic Colorectal Cancer Gastrointestinal cancers - Anticancer agents & Biologic therapy
18 Nov 2017 Alternate Schedule of Sunitinib Dosing May Be Used in Asian and Non-Asian Patients with mRCC Genitourinary cancers - Anticancer agents & Biologic therapy
18 Nov 2017 Close Clinical Monitoring Advised After Definitive Radiotherapy Treatment of Nasopharyngeal Carcinoma Head and neck cancers
18 Nov 2017 Oral Combination of Paclitaxel Shows Similar Bioavailability as i.v. Paclitaxel in Patients With Solid Tumours Anticancer agents & Biologic therapy
17 Nov 2017 ESMO Asia 2017 Press Release: Only one in five Indonesian Women are Aware of Cervical Cancer Screening
17 Nov 2017 ESMO Asia 2017 Press Release: ALEX study shows alectinib 600 mg more effective than crizotinib in Asian lung cancer patients
17 Nov 2017 ESMO Asia 2017 Press Release: Study Finds All Myanmar Mouth Cancer Patients Chew Betel Quid